EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Free Flap Failure in Antiphospholipid Syndrome: A Microangiopathic Mechanism beyond Thrombosis

Alexandru Stoian, Britt M.H.A. Op den Kamp, Judith Potjewijd, Ariela Loupatty, Shan S. Qiu, Rene R.W.J. van der Hulst, Stefania M.H. Tuinder

Journal of Reconstructive Microsurgery Open · 2026-07-01 · 11 (02) · e87-e90

DOI: 10.1055/a-2960-1446 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Antiphospholipid syndrome (APS), a multisystem autoimmune disorder characterized by arterial and venous thromboses, poses a significant risk to the success of free flap reconstruction. While the literature documents near-complete failure rates in patients with APS undergoing microsurgical procedures, comprehensive reports of intraflap microvascular complications are scarce. Methods We present two cases of complex scalp reconstruction patients with APS, both exhibiting progressive flap ischemia from the periphery to the center despite preserved arterial and venous Doppler signals. Results This pattern—marbled or livedo reticularis-like skin changes—suggested a microvascular pathogenesis, consistent with a lesser-known subtype of APS: microangiopathic antiphospholipid syndrome (MAPS). In both cases, immunologic evaluation confirmed the diagnosis of APS, prompting initiation of intravenous immunoglobulin therapy and immunosuppressive agents, which led to flap salvage and eventual wound closure. Conclusion Our findings advocate for early multidisciplinary collaboration between microsurgeons and immunologists in suspected APS cases. Furthermore, we propose that marbled flap appearance in the context of preserved pedicle signals may be an early clinical sign of MAPS, warranting prompt immunologic intervention to optimize outcomes.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →